Mounjaro and Alzheimer’s: Current Evidence and What Patients Should Know Written by Bolt Pharmacy Published on 24/7/2026 Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist licensed in the UK for treating type 2 diabetes mellitus in adults. Emerging research has explored potential links between diabetes medications and Alzheimer’s disease, given that type 2 diabetes increases […]
